In the UK, injections are usually given as hydroxocobalamin or cyanocobalamin
This trend positions North America to maintain a dominant position in the global market, even as other regions, such as Asia Pacific, begin to show promising growth due to increasing healthcare access and rising incidences of metabolic disorders
The glucagon component aids the body in burning stored energy, primarily from fat, rather than retaining it
Delivering a filler-like effect on the look of wrinkles,[2] our latest innovation targets the formation of wrinkles at their foundation
Newer licensed options such as the oral Wegovy pill, approved by the MHRA in June 2026, treat weight management only and do not treat endometriosis, though eligible people with the condition may be able to use them after assessment